raised beta 2-m was found in 16.4 % of patients with only extrarenal manifestations of sle , in 29.2 % of patients with renal manifestation but an endogenous creatinine clearance greater than 80 ml/min/1.73 m2 and in 65.7 % of patients with decreased creatinine clearance . beta 2-m was higher in sle than non-sle glomerulonephritides matched for creatinine clearance .
C0022646
renal
C0017658
glomerulonephritides